Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRS-060 in mild asthma
NCT03574805Phase 1Completed
- Sponsor
- Pieris Pharmaceuticals
- Start
- Jun 2018
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in asthma comparing PRS-060 with Placebo (2 arms). Primary endpoints: Number of participants with adverse events (AEs), Change in blood pressure and 9 more. Started Jun 2018; status: completed.
02
Drugs
elarekibep
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03574805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03574805.